Lv1
40 积分 2026-05-29 加入
In vivo nano-engineering T cells for CAR-T therapy
2个月前
已完结
Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
CAR T cells produced in vivo to treat cardiac injury
3个月前
已完结
Release Assays and Potency Assays for CAR T-Cell Interventions
3个月前
已完结
In vivo generation of CAR-T cells: Current obstacles, strategic solutions, and clinical translation
3个月前
已完结
n vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3个月前
已完结
皖公网安备34019202002308
